Barclays »

Tevogen Bio Hldgs shares owned by Barclays

Quarter-by-quarter ownership of Tevogen Bio Hldgs (TVGN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Tevogen Bio Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Tevogen Bio Hldgs held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tevogen Bio Hldgs by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $13k 33k 0.40
2024-06-30 $5.0k 7.5k 0.66

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding Tevogen Bio Hldgs

Portland Global Advisors
Polar Securities
Cantor Fitzgerald, L. P.
Geode Capital Management
BlackRock
BlackRock
Vanguard Group
New York State Common Retirement Fund
Northern Trust
State Street Corporation
Charles Schwab Investment Management
Barclays
AQR Capital Management
Jpmorgan Chase & Co
Alpine Partners VI

View all funds holding Tevogen Bio Hldgs